Onderzoeker
Tom Van Maerken
- Disciplines:Immunogenetica, Klinische genetica en moleculaire diagnostiek, Genetica, Kankertherapie
Affiliaties
- Vakgroep Biomoleculaire Geneeskunde (Departement)
Lid
Vanaf1 okt 2018 → Heden - Vakgroep Pediatrie en genetica (Departement)
Lid
Vanaf1 okt 2004 → 30 sep 2018
Publicaties
11 - 20 van 46
- Whole transcriptome profiling of liquid biopsies from tumor xenografted mouse models enables specific monitoring of tumor-derived RNA(2021)
Auteurs: Vanessa Vermeirssen, Jill Deleu, Annelien Morlion, Celine Everaert, Kimberly Verniers, Tom Van Maerken, Bram De Wilde, Jo Vandesompele, Anneleen Decock
Aantal pagina's: 1 - Whole transcriptome profiling of liquid biopsies from tumor xenografted mouse models enables specific monitoring of tumor-derived RNA(2020)
Auteurs: Jill Deleu, Vanessa Vermeirssen, Celine Everaert, Annelien Morlion, Kimberly Verniers, Jasper Anckaert, Jo Vandesompele, Tom Van Maerken, Anneleen Decock, Bram De Wilde
Aantal pagina's: 1 - ALK positively regulates MYCN activity through repression of HBP1 expression(2019)
Auteurs: Shana Claeys, Geertrui Denecker, Kaat Durinck, Bieke Decaesteker, Liselot Mus, Siebe Loontiens, Suzanne Vanhauwaert, Kristina Althoff, Caroline Wigerup, Daniel Bexell, et al.
Pagina's: 2690 - 2705 - Nosocomial outbreak of extended-spectrum β-lactamase-producing Enterobacter cloacae among cardiothoracic surgical patients : causes and consequences(2019)
Auteurs: A Noël, C Vastrade, S Dupont, M de Barsy, TD Huang, Tom Van Maerken, Isabel Leroux-Roels, B Delaere, L Melly, B Rondelet, et al.
Pagina's: 54 - 60 - Cost-effective and robust genotyping using double-mismatch allele-specific quantitative PCR(2019)
Auteurs: Steve Lefever, Ali Rihani, Joni Van der Meulen, Filip Pattyn, Tom Van Maerken, Jo Van Dorpe, Jan Hellemans, Jo Vandesompele
- Whole transcriptome profiling of liquid biopsies from patient-derived xenograft (PDX) models(2019)
Auteurs: Vanessa Vermeirssen, Anneleen Decock, Kimberly Verniers, Celine Everaert, Annelien Morlion, Jill Deleu, Tom Van Maerken, Bram De Wilde, Jo Vandesompele
Aantal pagina's: 1 - The ornithine decarboxylase G316A promoter polymorphism impacts neuroblastoma clinical outcome and may identify patients particularly susceptible to polyamine inhibition(2018)
Auteurs: Laura Gamble, Stefania Purgato, Simone Di Giacomo, Amanda Russell, Paolo Pigini, Emanuele Valli, Lesley Ashton, Tom Van Maerken, Jo Vandesompele, Rogier Versteeg, et al.
Aantal pagina's: 1 - Performance of the preanalytical check module of the Stago STA R Max2 mechanical endpoint detection analyzer for assessing the impact of hemolysis, lipemia, and icterus on aPTT and PT(2018)
Auteurs: LISA FLORIN, Matthijs Oyaert, Tom Van Maerken, Katrien Devreese
Pagina's: e109 - e112 - Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients(2018)
Auteurs: Fjoralba Zeka, Anneleen Decock, Alan Van Goethem, Katrien Vanderheyden, Fleur Demuynck, Tim Lammens, Hetty Helsmoortel, Joëlle Vermeulen, Rosa Noguera, Ana P. Berbegall, et al.
- Analytical and diagnostic performance evaluation of the new Sysmex UF-5000 for automated urine sediment analysis(2017)
Auteurs: Matthijs Oyaert, Ruben Govaert, Joris Delanghe, Veronique Stove, Tom Van Maerken
Aantal pagina's: 1